Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: Lab Invest. 2011 Dec 12;92(3):420–436. doi: 10.1038/labinvest.2011.185

TABLE 2.

Comparison of Reciprocal Relationships between CAF and CD133+ or CD133− Colon Cancer Cells

   A. CD133+ vs. CD133− cells
RECEPTOR (Gene Symbol) p-value Fold Change
CXCR4 chemokine (C-X-C motif) receptor 4 0.02* 4.07
CD74 CD74 molecule, major histocompatibility complex, class II invariant chain 0.04* 3.12
ITGB8 integrin, beta 8 0.01* 2.18
FGFR2 Fibroblast growth factor 2 0.03* 1.21
LIGAND
CXCL12 chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) 0.89 1.02
MIF macrophage migration inhibitory factor (glycosylation-inhibiting factor) 0.88 1.01
VTN vitronectin 0.82 −1.04
FGF ligands 1,2,7,5,13, fibroblast growth factor ligands N.S.
   B. CAF vs. CD133+ or CD133− cells
LIGAND CAF vs CD133+
p-value
CAF vs CD133+
Fold change

CAF vs CD133−
p-value
CAF vs CD133−
Fold change
CXCL12 chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1) 0.0003* 3.73

0.0002* 3.8

MIF macrophage migration inhibitory factor (glycosylation-inhibiting factor) 3.71E-05* 1.87

4.01E-5* 1.85

VTN vitronectin 1.54E-05* 7.29

1.72E-05* 7.03

FGF2 fibroblast growth factor 2 (basic) 1.49E-09* 28.32

1.48E-09* 28.51

FGF7 fibroblast growth factor 7 (keratinocyte growth factor) 3.52E-07* 15.35

3.52E-07* 15.36

FGF13 fibroblast growth factor 13 3.26E-07* 8.10

5.22E-07* 7.9

FGF5 fibroblast growth factor 5 2.83E-05* 2.57

3.50E-05* 2.48

FGF1 fibroblast growth factor 1 7.48E-05* 2.12

3.53E-05* 2.35
   C. CD133+ or CD133− Cells vs.CAF
RECEPTOR (GENE SYMBOL) CD133+ vs. CAF
p-value
CD133+ vs. CAF
Fold change

CD133− vs. CAF
p-value
CD133− vs. CAF
Fold change
CXCR4 chemokine (C-X-C motif) receptor 4 0.007* 5.26

0.56 1.29

CD74 CD74 molecule, major histocompatibility complex, class II invariant chain 0.03* 3.32

0.89 1.06

ITGB8 integrin, beta 8 0.009* 2.04

0.73 −.107

FGFR2 Fibroblast growth factor 2 0.005* 1.48

0.015* 1.22
*

Statistical significance demonstrated at p-value ≤ 0.05